Колофорт

Quick links to important sections

Колофорт

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Колофорт

Colofort is a brand name for an oral powder medication used for bowel cleansing, also known as bowel irrigation. Its primary indication is for the preparation of the colon before diagnostic procedures, such as a colonoscopy or radiological examination, or prior to colorectal surgery. The goal of this preparation is to thoroughly evacuate the bowels to ensure the physician has a clear view of the colon wall.

Key Composition and Mechanism of Action

Colofort contains a combination of active ingredients, principally Macrogol 4000 (also known as polyethylene glycol or PEG 4000), along with various electrolytes (sodium sulfate, sodium chloride, potassium chloride, and sodium bicarbonate) to maintain the body's electrolyte balance during the bowel cleansing process.

Macrogol 4000 functions as an osmotic laxative. It is a biologically inert, non-absorbable polymer that acts by binding water molecules within the gastrointestinal tract. This process prevents the reabsorption of water, increases the volume and hydration of the stool, and ultimately triggers a strong diarrheal effect to clean out the colon.

Unlike osmotic laxatives used to treat constipation, the concentration and volume of the Colofort solution are specifically formulated to produce a rapid and complete purge of the entire large intestine. Because of its potent and rapid action, Colofort is a prescription-only medication administered under medical supervision, especially for elderly patients or those with poor general health.

What side effects are possible with Колофорт?

Possible Side Effects and Safety Information

The safety profile for this Macrogol and electrolyte preparation is defined by regulatory classifications that separate expected reactions from clinically significant risks documented by government health authorities.


Officially Classified Adverse Reactions

Adverse effects are grouped by the physiological system affected and their reported frequency in official labeling:

  • Gastrointestinal Disorders: Reactions such as abdominal distension, nausea, vomiting, abdominal pain, and anal discomfort are often classified as Very Common (ge 10%). Stool urgency is generally classified as Uncommon.
  • Immune System Disorders: Hypersensitivity reactions, including anaphylaxis, angioedema, pruritus, and urticaria, are documented as potential effects with a frequency of Not Known (cannot be estimated from available data).
  • Other Systems: Headache and dizziness are listed among the documented effects, along with potential fluid and electrolyte disturbances.

Serious Adverse Reactions and Safety Constraints

Regulatory documents emphasize that the medicine is contraindicated in patients with conditions like gastrointestinal obstruction, bowel perforation, toxic megacolon, or gastric retention. Serious adverse reactions noted in official warnings include:

  • Cardiac Events: Potential for cardiac arrhythmias (such as atrial fibrillation) in susceptible individuals.
  • Neurological Events: Seizures and loss of consciousness, often associated with significant fluid and electrolyte abnormalities.
  • Gastrointestinal Injury: Reports of colonic mucosal ulcerations and ischemic colitis.

Population-Specific Safety Notes

The official safety information notes that older adults are at an increased risk for serious complications. Caution, including monitoring of fluid and electrolyte status, is advised for patients with pre-existing renal impairment or cardiac risk factors. The intended rapid cleansing action may also cause a transient reduction in the absorption and efficacy of other orally administered medications.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Scope

Domain Official Regulatory Statement
Documented overdose presentations Overdose from ingestion of excessive volumes of the solution is officially documented to result in severe fluid and electrolyte disturbances. Manifestations include excessive diarrhea, significant vomiting, severe abdominal pain, and profound thirst.
Physiological systems affected Adverse effects involve the gastrointestinal system, and severely, the cardiovascular system, central nervous system, and renal system, primarily through resulting electrolyte imbalances (e.g., hyponatremia).
Population-specific overdose notes Geriatric patients face increased documented risks, with isolated reports of serious adverse events following severe fluid loss, including asystole or pulmonary edema. Caution is also required for individuals with impaired renal function.

Emergency Response and Management

Classification Type Official Regulatory Statement
Severity classification Overdose may lead to severe or life-threatening outcomes, specifically those driven by profound fluid and electrolyte abnormalities, such as seizures and cardiac arrhythmias.
When immediate medical help is required Individuals must seek immediate emergency medical attention for any suspected overdose. Contact emergency services immediately if the person has collapsed, experienced a seizure, or has trouble breathing.

Official Overdose Statements

  • Treatment is strictly symptomatic and supportive, focusing on the rapid correction of fluid and electrolyte abnormalities using methods like intravenous fluids.
  • No known specific antidote is listed in the official regulatory documentation.
  • Hospital monitoring is required, including assessment of serum electrolytes, creatinine, and vital signs.

The official overdose profile emphasizes that the primary risk is severe, sudden fluid loss, which defines the clinical picture and mandates immediate intervention. The appearance of documented severe manifestations, such as cardiac events or seizures, is the critical trigger for contacting emergency medical services, as management requires advanced supportive care.

Therapeutic Uses of Колофорт

Therapeutic Focus of Kolofort

Kolofort is a multicomponent medication designed to address functional gastrointestinal disorders. Its primary application centers on managing the symptoms associated with Irritable Bowel Syndrome (IBS) and other functional disturbances of the digestive tract.

Main Uses

The medication is utilized to manage a complex of symptoms involving the lower gastrointestinal tract. It is typically applied in the following contexts:

  • Irritable Bowel Syndrome (IBS): Addressing the diverse manifestations of the condition, including various types of stool irregularities.
  • Functional Abdominal Pain: Managing persistent or recurrent discomfort where no structural abnormality is present.
  • Gastrointestinal Dysfunctions: Assisting in the normalization of bowel motility and sensitivity.

Benefits and Action

Kolofort works through a combined mechanism that targets several physiological pathways simultaneously. The benefits of its application include:

  • Normalization of Motility: It helps regulate the motor function of the digestive system, which can assist in resolving both constipation and diarrhea-related symptoms.
  • Reduction of Visceral Hypersensitivity: The medication aims to lower the sensitivity of the intestinal wall receptors, which helps decrease the perception of pain and bloating.
  • Restoration of Transit Balance: By acting on the nervous regulation of the gut, it supports a more consistent and natural movement of content through the intestines.
  • Reduction of Inflammation Markers: It has been observed to influence the underlying low-grade inflammatory processes often associated with functional bowel disorders.

Through these actions, the medication focuses on improving the overall functional state of the digestive system and enhancing the patient's daily comfort by stabilizing bowel habits and reducing abdominal tension.

Eligibility and Restrictions for Use

The eligibility for Колофорт (Macrogol 4000 and electrolytes for colon cleansing) is strictly defined by regulatory guidelines based on age and pre-existing medical conditions.

Age-Related Eligibility

The medicine is formally indicated for use only in adults 18 years of age and older. Use is not recommended for the pediatric population (children and adolescents under 18) for this specific high-dose preparation, as safety is not established.

Absolute Contraindications

The preparation is contraindicated in patients with conditions that compromise the gastrointestinal tract. These absolute non-eligibility rules include confirmed or suspected gastrointestinal obstruction, ileus, or perforation. It must also not be used in cases of toxic megacolon, severe inflammatory bowel diseases (like active Crohn's disease or ulcerative colitis), or unexplained abdominal pain.

Conditional Use and Restrictions

Increased precautions and medical oversight are required for patients with certain systemic conditions, including those with renal (kidney) insufficiency, hepatic (liver) insufficiency, or known cardiac arrhythmia or circulatory failure. Additionally, use during pregnancy and lactation is only permitted under strict indication as determined by a healthcare provider.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Колофорт (Colofort), which contains Macrogol and electrolytes, is predominantly non-systemic, focusing on its strong osmotic laxative action within the gastrointestinal tract. This activity dictates necessary constraints on co-administered substances, as documented by regulatory authorities.


Interaction-Related Restrictions

The primary regulatory concern is the reduced efficacy of all oral medications taken concurrently. This is due to the rapid, cleansing effect of the solution, which prevents adequate absorption. To mitigate this, a mandatory timing separation rule is specified: oral medications must not be taken within one hour before the start or during the administration of the bowel preparation. Furthermore, co-administration with other laxatives is prohibited, as this combination increases the risk of severe fluid and electrolyte disturbances.


Use-with-Caution Combinations

Official product labeling identifies specific substance classes requiring caution due to potential pharmacodynamic risks. Combining Колофорт with Diuretics or medications that lower the seizure threshold may increase the risk of serious fluid and serum chemistry abnormalities. Caution is also advised when co-administering with NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), especially in patients with impaired renal function, due to the heightened risk of renal injury associated with volume depletion. Finally, a physical interaction exists with starch-based thickeners; Macrogol may reverse their thickening property, which creates an increased risk of aspiration.

Mechanism of Action

Osmotic Fluid Dynamics and Water Binding

Macrogol 4000 functions as an inert osmotic agent with a non-systemic, physical action. The polymer's structure facilitates hydrogen bonding with water molecules in the intestinal lumen. This binding and the high molecular weight of the polymer establish a steep osmotic gradient that mechanically halts the normal transepithelial reabsorption of fluid. This initial step results in a massive, dose-dependent increase in intraluminal volume and hydration, providing the necessary bulk for the subsequent physiological response.


Volume-Driven Peristalsis and Motility

The sustained presence of this large fluid volume acts as a physical distension agent against the colonic wall, thereby stimulating stretch receptors embedded in the gut's smooth muscle. This mechanical activation initiates powerful, synchronized High-Amplitude Propagated Contractions (HAPCs). The physiological effect of these contractions is a rapid acceleration of intestinal transit, resulting in the expulsion of contents.


Homeostatic Support by Electrolyte Balance

The essential salts included in the formulation maintain the solution's isotonicity relative to the plasma. This mechanism reduces the magnitude of net shifts of water or essential ions across the gut lining. This physiological stabilization allows the necessary large volume of osmotic fluid to be administered while mitigating large shifts of systemic water and ions.

Dosage and Administration Information

Official Administration Guidelines for Bowel Cleansing

The administration of the Polyethylene Glycol-Electrolyte Solution (PEG-ES) formula, which is used for colon cleansing, must strictly follow the acute, regulated instructions outlined in official prescribing information. The drug is provided as a powder for oral solution and is not for direct ingestion.


Administration Scope Official Label Instructions
Route of Administration The solution is administered orally or, if necessary, via nasogastric tube.
Dosing Schedule (Adult) Consumption requires drinking a standard portion of 240 mL (8 fl. oz.) every 10 minutes. Total consumption is typically up to 4 Liters (1 gallon) or until the rectal discharge is clear.
Timing and Frequency The dosing regimen is typically split, beginning in the early evening of the day prior to the procedure and concluding the next morning. The solution must be consumed within the prescribed time intervals.
Preparation Requirements The entire powder must be reconstituted with water to the final volume; no additional ingredients or flavorings should be added. The solution should be shaken well until fully dissolved.
Dietary Conditions Patients must fast from solid food for at least two hours prior to starting administration. Intake of all liquids, including clear liquids, must stop a minimum of two hours before the scheduled procedure time.
Pediatric Use For pediatric patients aged six months and older, the prescribed rate is 25 mL/kg/hour until the stool is clear, as determined by a healthcare provider.

The overall use protocol is defined by these specific, non-negotiable parameters, which govern the volume, rate, and timing of consumption to ensure complete colon cleansing prior to the medical examination.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Колофорт

The medication known by the brand name Колофорт contains polyethylene glycol (PEG) with electrolytes, a solution widely studied for its intended purpose: preparing the colon for medical procedures. The research evidence available describes how this class of preparation has been evaluated in large-scale clinical trials and summarized in aggregated scientific reviews.


Evidence for Use in Colo-Rectal Preparation

Studies conducted on PEG-electrolyte solutions were primarily designed as short-term Randomized Controlled Trials (RCTs), a research method used to compare different preparations or other cleansing regimens. Research examined the use of this preparation for the preparation of the colon before critical diagnostic examinations and colorectal surgery.

In these trials, researchers primarily monitored specific outcomes related to the success of the procedure, specifically the Quality of Bowel Cleansing. This was evaluated using validated functional scales to check whether the lining of the colon was sufficiently visible for the examination. Findings describe patterns observed in the studies that related to the specific volume and dosing schedules used. This evidence describes the metrics evaluated for clearance.


Research on Procedural Success and Patient Tolerability

Studies explored outcomes related to the overall success of the procedure, such as whether the medical professional was able to complete the examination fully. Research describes this class of preparations being used in many studies for comparison in the broader evidence landscape.

Research also describes changes measured during the study period related to patient compliance and adherence to the regimen. These findings help contextualize how patients reported their experience, noting that completing the full preparation regimen was observed in some studies to present difficulties.


Extended Follow-Up and Unanswered Research Questions

Since the intended purpose of this medication is a single, acute event—the cleansing of the colon—outcomes were monitored over defined time intervals that concluded immediately following the completion of the regimen.

Given the short duration of the preparation, there is limited information for long-term outcomes, and extended effects are not fully established or studied. The research describes that a primary limitation involves patient compliance with the regimen, and studies report that this variability is associated with the measured quality of bowel cleanliness.

Key Studies & References Polyethylene glycol-electrolyte solution (PEG-ES): MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Колофорт (FAQ)

Q: How quickly does Kolofort start working?

A: Official product information states that the first bowel movement typically occurs approximately one hour after you start consuming the solution. This timing is a general expectation and can vary depending on individual factors and strict adherence to the administration schedule. The preparation's goal is complete colon cleansing for the procedure.

Q: Is it true that Kolofort helps with bloating?

A: No, according to regulatory documents, a bloated feeling (abdominal distension) is frequently reported as a side effect of taking the solution, not a beneficial effect. The preparation is designed for rapid colon cleansing, and the large volume of fluid and gas production can cause temporary abdominal discomfort.

Q: What are the most common side effects of Kolofort that people talk about?

A: Official safety documents list several effects that are classified as "Very Common," meaning they occur in more than 1 in 10 patients. These typically include abdominal pain, a sense of fullness or bloating, nausea, and vomiting. These temporary effects are related to the volume and rapid action of the cleansing solution.

Q: Is it true that Kolofort has no systemic action?

A: Yes, this is generally consistent with the drug’s description. The active ingredient, Macrogol, is a polymer that is minimally absorbed into the body. Its action is physical and osmotic, meaning it works locally in the bowel by binding water, rather than having systemic effects throughout the body.

Q: Can Kolofort be taken if I have gastritis?

A: Regulatory documents state that this preparation is contraindicated in severe or acute gastrointestinal conditions. Based on this, the product's use is cautioned against if a patient is experiencing acute symptoms such as unexplained abdominal pain, severe nausea, or vomiting.

Q: Can Kolofort be taken if I am already taking vitamins?

A: Due to the preparation's rapid cleansing action, it can prevent the absorption of any oral medications or supplements. Official guidance indicates that any oral medicines, including vitamins, should be separated from the preparation by the specified time interval.

Q: What is the difference between Kolofort and other medicines for the bowel?

A: Kolofort is officially classified as an osmotic laxative with the specific, acute purpose of complete colon cleansing. This function differs from standard, lower-dose laxatives or other bowel medicines that are used for the long-term management of chronic constipation or functional issues.

Q: Is Kolofort a homeopathic remedy or an official medicine?

A: Official regulatory records classify Kolofort as a human prescription drug. It is listed as an osmotic laxative with a defined active pharmaceutical ingredient (Macrogol and electrolytes) and is administered under medical supervision.

Q: How long is the Kolofort regimen supposed to last?

A: This product is intended for a single, acute cleansing procedure. The administration continues until either the entire prescribed volume is consumed or the fluid being discharged from the rectum is completely clear, as required for the medical examination.

Q: Can Kolofort be taken for prevention?

A: The sole official indication for this drug is the acute preparation of the colon for a diagnostic procedure. It is not approved or intended for regular or preventative use outside of this specific, regulated context.

Q: Is Kolofort addictive?

A: Since the active substance is minimally absorbed and works locally in the gut, it does not have the mechanism to cause systemic addiction. However, regulatory caution notes that prolonged or excessive use of any laxative is generally not recommended.

Q: Does Kolofort affect the function of the liver or kidneys?

A: Regulatory information describes that special caution and monitoring may be necessary for patients who have pre-existing kidney or liver impairment, particularly older adults. This is due to the potential risk of fluid and electrolyte disturbances during the bowel cleansing process.

Q: Does Kolofort help with Irritable Bowel Syndrome (IBS)?

A: The only use approved by regulatory authorities is the acute cleansing of the colon for a medical procedure. This drug is not indicated for the long-term treatment of functional gastrointestinal disorders, such as Irritable Bowel Syndrome (IBS).

Q: Do I need to follow a special diet while taking Kolofort?

A: Yes, regulatory information indicates that compliance with dietary conditions is required for this preparation. Patients are instructed to fast completely from solid food starting at least two hours before administration and continuing throughout the entire cleansing regimen, consuming only clear liquids.

Q: What should I do if I miss a dose of Kolofort?

A: Official guidance for a missed dose is to continue the scheduled regimen. However, if you realize you cannot complete the entire prescribed volume before your examination is scheduled, official guidance suggests that the patient should contact their healthcare provider if they are unable to complete the regimen before the scheduled procedure.

Q: What time of day is best to take Kolofort?

A: The official administration plan typically involves a split-dose regimen. This means the preparation often starts in the early evening the day before the procedure, with the remaining portion consumed on the morning of the examination.

Q: How can I find out if the active substances in Kolofort are right for me?

A: Kolofort is a prescription-only medication. Because eligibility depends on a patient's full medical history, a healthcare provider is the only person qualified to assess a patient’s full medical history and determine eligibility based on regulatory guidelines.

Q: Are there any prohibited or dangerous components in Kolofort?

A: Kolofort contains active substances—Macrogol and electrolytes—that are approved by regulatory bodies. It is officially classified as a human prescription drug, and its composition is reviewed by government health authorities.

Q: Why do some people say that Kolofort doesn't work?

A: Research on bowel preparations indicates that the success of the cleansing is highly dependent on strict patient adherence to the full, rigorous regimen. Studies have noted that variability in adherence to the high-volume preparation is the primary factor that can compromise the final cleansing result.

Q: Is the action of Kolofort in tablets different from drops (if available)?

A: The official dosage form of this specific colon cleansing preparation is a powder that must be reconstituted into an oral solution. Regulatory documents do not list tablets or liquid drops as approved forms for this high-volume cleansing procedure.

Q: Can Kolofort cause drowsiness?

A: Drowsiness (somnolence) is not specifically listed among the commonly classified side effects in official product information. However, other central nervous system effects such as headache and dizziness are documented.

Q: Did studies show that Kolofort is safe for long-term use?

A: Due to the drug's intended purpose as an acute, single cleansing event, clinical data regarding its safety and effects for long-term use are limited. Long-term outcomes or effects beyond the period of preparation are not fully established in studies.

Q: Are there known cases of Kolofort interacting with food products?

A: One specific interaction noted in product information is a physical counteraction with starch-based food thickeners, where the Macrogol may reduce their thickening property. Solid food intake is contraindicated during the administration regimen itself.

Q: Why is Kolofort sometimes prescribed for stress?

A: The sole official indication for this medicine, as designated by government health authorities, is the acute preparation and cleansing of the colon for medical examinations. Any use outside of this official scope is not supported by the regulatory label.

Q: Can Kolofort be taken if I have diabetes?

A: While the product is typically formulated to be sugar-free, regulatory information indicates that patients with underlying risk factors, such as diabetes, may require careful monitoring. This is due to the potential risk of fluid and electrolyte imbalances.

Q: How is Kolofort different from antispasmodics?

A: Kolofort is officially classified as an osmotic laxative, which achieves its effect by physically binding water in the bowel to facilitate evacuation. This mechanism is distinct from antispasmodic medicines, which work primarily by acting on the smooth muscle contractions of the digestive tract.

Q: Can Kolofort cause constipation or diarrhea?

A: The preparation's primary and intended effect is to induce controlled, large-volume diarrhea, which is necessary for the complete cleansing of the colon. This is an expected and required physiological response, not an adverse reaction.

Q: Should I stop taking Kolofort if I feel better?

A: Official instructions indicate that consumption should continue until either the entire prescribed volume is taken or the discharged fluid is entirely clear and free of solid matter. The regimen is completed based on the cleansing outcome, not subjective feelings.

Q: Does Kolofort have a cumulative effect in the body?

A: No. Since the active substance, Macrogol, is minimally absorbed from the intestinal tract into the bloodstream, it does not accumulate in the body. Its function is purely physical, acting locally within the gastrointestinal tract to facilitate the cleansing process.

Q: How should Kolofort be stored and disposed of if it is already diluted?

A: Regulatory storage instructions for the reconstituted solution specify that it must be kept refrigerated. The solution should be used within 48 hours of preparation, and any remaining, unused portion should be discarded in accordance with local requirements after that time.

How should Колофорт be stored and disposed of?

How to Store and Dispose of Kolofort

The storage and disposal requirements for Kolofort are strictly defined in the official governmental labeling to maintain the product's stability and ensure safety.

Mandatory Storage Conditions

Kolofort must be kept at a temperature not exceeding 25 C. The medicine requires specific environmental protection, demanding storage in a dry place and protected from light.

The product must remain in its original primary packaging and must be stored out of the sight and reach of children.

Stability and Disposal

The official shelf-life is three years, and the medicine should not be used after the expiration date printed on the package. For disposal, any unused or expired Kolofort must be discarded in accordance with local legal requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Колофорт found in:

A-Z Index: